Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Cardiovascular Risk Factor Burden in People With Incident Type 2 Diabetes in the U.S. Receiving Antidiabetic and Cardioprotective Therapies.

Montvida O, Cai X, Paul SK.

Diabetes Care. 2019 Apr;42(4):644-650. doi: 10.2337/dc18-1865. Epub 2019 Jan 24.

PMID:
30679305
2.
3.

Long-term sustainability of glycaemic achievements with second-line antidiabetic therapies in patients with type 2 diabetes: A real-world study.

Montvida O, Shaw JE, Blonde L, Paul SK.

Diabetes Obes Metab. 2018 Jul;20(7):1722-1731. doi: 10.1111/dom.13288. Epub 2018 Apr 15.

PMID:
29536608
4.

Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes.

Montvida O, Shaw J, Atherton JJ, Stringer F, Paul SK.

Diabetes Care. 2018 Jan;41(1):69-78. doi: 10.2337/dc17-1414. Epub 2017 Nov 6.

PMID:
29109299
5.

Effectiveness of biologic and non-biologic antirheumatic drugs on anaemia markers in 153,788 patients with rheumatoid arthritis: New evidence from real-world data.

Paul SK, Montvida O, Best JH, Gale S, Pethoe-Schramm A, Sarsour K.

Semin Arthritis Rheum. 2018 Feb;47(4):478-484. doi: 10.1016/j.semarthrit.2017.08.001. Epub 2017 Aug 3.

6.

Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients.

Montvida O, Klein K, Kumar S, Khunti K, Paul SK.

Diabetes Obes Metab. 2017 Jan;19(1):108-117. doi: 10.1111/dom.12790. Epub 2016 Oct 18.

PMID:
27629433
7.

Weight gain in insulin-treated patients by body mass index category at treatment initiation: new evidence from real-world data in patients with type 2 diabetes.

Paul SK, Shaw JE, Montvida O, Klein K.

Diabetes Obes Metab. 2016 Dec;18(12):1244-1252. doi: 10.1111/dom.12761. Epub 2016 Sep 21.

PMID:
27502528

Supplemental Content

Loading ...
Support Center